Patients in the control group received only NIPPV.
对照组则单纯给予NIPPV治疗。
Objective To study the effects of NIPPV for patients with COPD and SAS in acute exacerbation period and stable period.
目的探讨无创正压通气(NIPPV)在COPD并SAS急性加重期及稳定期治疗的效果评价。
Conclusion: Xingnaojing Injection shows a great clinical value in respiratory failure of AECOPD when treated with NIPPV.
结论:醒脑静注射液在NIPPV治疗AECOPD呼吸衰竭中具有极高的临床应用价值。
应用推荐